Explanatory note
(This note is part of the Order)
These Regulations, which apply to the United Kingdom, control the price of certain generic medicines which are sold for the purposes of the national health services in England and Wales, Scotland and Northern Ireland (see the definition of “health service” in section 38(6) of the Health Act 1999). They apply only to the medicines specified in the list of controlled prices which is published on the web site at the address http://www.doh.gov.uk/generics. Printed copies of the list are available from the Department of Health, Room 130, Richmond House, 79 Whitehall, London SW1A 2NS. Moreover, the Regulations apply only to medicines in respect of which marketing authorisations have been granted (regulation 2).
The maximum price for such medicines is based on the “specified price” which is defined in regulation 2(1) as the price specified in the list of controlled prices. Provision is made for the maximum price to be increased (regulations 3 and 4).
Information on the sales of specified generic medicines is required to be supplied to the Secretary of State (regulation 5).
Provision is also made for enforcing the Regulations and paying interest on outstanding payments (regulation 6 and Schedule 1), the recovery of penalties and excess sums (regulation 7 and Schedule 2) and appeals (regulation 8).
A Regulatory Impact Assessment has been prepared and copies may be obtained also from the Department of Health, Room 130, Richmond House, 79 Whitehall, London SW1A 2NS. A copy has also been placed in the Library of each of the Houses of Parliament.